|
Paratuberculosis (Johne’s Disease)
and Ovine Progressive Pneumonia
By William P. Shulaw, DVM, MS
The Ohio State University
Paratuberculosis (Johne’s Disease)
I. ETIOLOGY
A. Mycobacterium paratuberculosis -
an acid-fast bacterium now known to share greater than 90 percent DNA
homology with Mycobacterium avium, but still usually
referred to as a distinct species. It has been proposed that it be
classed as a subspecies of M avium.
B. Mycobacterium paratuberculosis is
capable of causing disease (Johne’s disease) in all ruminants and
paratuberculosis has been described in several wild and captive exotic
species. Recent research has shown that Mycobacterium paratuberculosis
may be involved in some cases of Crohn’s disease in humans.
C. May survive for extended periods in soil, water
and manure in the environment; lives intracellularly in the animal and
resists attempts by macrophages to kill inside the phagolysosome; is
resistant to many common disinfectants but may be killed by cresylic
acid compounds and sodium orthophenylphenol (Amphyl and O-Syl -
National Laboratories)
D. Worldwide, various "strains" have been
isolated from sheep, goats, and red deer in New Zealand. A pigmented
and an "Icelandic" strain have been described from Europe.
The existence of "strains" is now an accepted premise and
has been documented by RFLP and DNA probing.
II. TRANSMISSION AND PATHOGENESIS
A. Contaminated food, water, bedding, and soiled
udders are thought to be the major routes of spread of the organism.
Recent studies in cattle suggest that colostrum and milk may provide
significant exposure in some herds. To this author’s knowledge, no
studies of milk-borne transmission in sheep have been reported,
however, it is likely that it occurs.
B. Young animals less than aiz months of age are thought to be the
most susceptible animals to infection; older animals may be more
resistant to infection and development of disease but can develop a
delayed hypersensitivity or serological response thus interfering with
some diagnostic tests.
C. Intrauterine infection of the fetus in cattle
has been well documented; ultimate disease status of the offspring is
unknown. A confirmed isolation of Mycobacterium paratuberculosis
from a sheep fetus in our laboratory was found in 1989 and again in
1990. Another report has demonstrated antibodies to Mycobacterium
paratuberculosis in the serum of colostrum-deprived lambs.
D. Organisms enter the intestine and may enter the
lamina propria via the dome or "M" cells of the Peyer’s
patches in the small intestine. These cells are involved with the
uptake of macromolecules and other particles. This is an active
process which may contribute to the presentation of bacteria to
macrophages. Macrophages phagocytize the organisms but generally are
unable to kill them. Organisms multiply inside the macrophage which
eventually dies.
Cellular responses to the proliferating
organisms and bacterial and host cell remnants create the typical
thickening and macro and microscopic distortion of the gut wall.
Hypersensitivity reactions may increase the cellular response.
Infected macrophages and cellular debris enter lymph vessels and
travel to the mesenteric lymph nodes. Spill over of the processes
may lead to cecal and colon involvement but this disease is
basically a small intestinal disease.
Evidence suggests that, at times, a bacteremia
may occur which may send organisms to other parts of the body.
Organisms have been isolated from the endometrium and placentomes
in the female bovine. The bacterium is also known to be present in
the milk of some infected cows.
Recent research suggests that Mycobacterium
paratuberculosis may stimulate cytokine production, such as
tumor necrosis factor and possibly others, by the infected
macrophage. Cytokines may serve to modulate the disease process,
upregulate the activity of other agents such as that of OPP virus,
or directly cause the wasting seen in this disease. All these
actions have been demonstrated in AIDS patients with opportunistic
infections such as M avium. It is now well accepted
that much of the change seen in paratuberculosis and Crohn’s
disease occurs as a result of an abnormal immune response.
E. Changes in the intestinal wall may lead to
enteric protein loss and malabsorption. Cytokine production may
contribute to the observed signs but the possible mechanisms are yet
not well characterized. The characteristic sign in sheep is wasting
and emaciation with normal stools or intermittent diarrhea. Profuse
watery diarrhea as seen in cattle is not a common feature of
the disease in sheep and goats.
III. CLINICAL SIGNS
A. Emaciation or wasting disease unresponsive to
anthelmintics and antibiotics is the usual sign.
B. Appetite is often good, in spite of weight loss,
until the animal is near death.
C. Normal stools are the usual observation even in
clinically-diseased animals, but intermittent diarrhea or softened,
pasty stools are occasionally observed.
D. Intermittent low grade fever may be observed.
E. Intermandibular edema, lethargy, and depression
are sometimes seen.
IV. DIFFERENTIAL DIAGNOSIS
A. intestinal parasitism
B. chronic malnutrition
C. caseous lymphadenitis with internal abscesses
D. ovine progressive pneumonia
E. environmental toxins, and neoplasia
V. DIAGNOSTIC TESTS
A. Fecal or tissue culture may be unreliable in
sheep using standard techniques used for cattle feces. It is the
generally recognized "official" test and may require
eight-24 weeks for colonies to be observed. Most laboratories hold
cultures 12-16 weeks before reporting. Several reports from around the
world have described difficulties in growing the bacteria from known
infected sheep tissues and feces.
In goats fecal and tissue culture using
cattle-adapted techniques seems to work satisfactorily. The
existence of host-adapted "strains" may occasionally
cause problems, however.
B. Necropsy and histopathology - may have some
gross and microscopic lesions atypical of cattle
1. Corrugations of the mucosa of the small
intestine and cecum are not always seen as is common in cattle.
2. The colon and rectum are not regularly
involved grossly - disease is more often confined to the small
intestine.
3. Cording, or prominence of the mesenteric
lymphatics, is common as are swollen mesenteric lymph nodes.
4. Histopathologically, a great amount of
variation can exist in the type of lesions seen ranging from low
to very high numbers of bacteria observed on acid-fast staining,
and diffuse epithelioid cell proliferation versus tubercle
formation with giant cells. Necrosis, caseation, calcification,
and fibrous tissue encapsulation may be observed more commonly in
sheep than cattle. This variation may be a result of strain
differences of organisms and of differences in the ability of the
animal to mount an effective immune response.
C. Acid-fast staining of mucosal smears or lymph
node smears reveals the presence of typical clumps of bacteria and
acid-fast bacteria within macrophages
D. Intradermal johnin testing may yield many false
positive and false negatives; however, the absence of any positives in
a screening test of all animals may suggest that the herd or flock is
negative. This test is not widely practiced in sheep and goats.
E. Serology
1. Complement fixation is the official test in
some countries for cattle, but may be less frequently used in
sheep. Cross reactions with Corynebacterium spp. have been
reported, and the test has low sensitivity.
2. ELISA - may be very useful in the future
but, problems with specificity make it less useful in culling
individual animals except perhaps in high prevalence flocks. This
assay lacks standardization at present and the difficulty of using
culture as the "gold standard" complicates validation of
tests.
3. Agar gel immunodiffusion (AGID) has had
limited description for use in field cases. Most reported work
done in sheep has been by the ADRI in Ontario, Canada, and
investigators in Spain and at The Ohio State University. This test
may be our most sensitive and specific serologic test in sheep,
however, it may still lack sufficient sensitivity in subclinical
animals to screen flocks.
The results of our studies (OSU) suggest
low sensitivity but good specificity making it a good test for
confirmation of clinical disease; use as a screening test in
infected flocks may result in the finding of some non-clinical
animals, but it will not find all of them.
F. DNA probe - The current probe available from
IDEXX will detect the organism reliably, but the format and processing
steps are only approved for cattle. The specificity is very high so
that positives are true positives, but research has indicated that
current technology requires that 103 or 104
organisms per gram of feces before the test will be positive. Fecal
culture techniques used in cattle detect fewer numbers of bacteria in
that species. The probe technique can be useful, but is currently
quite expensive in most labs making it impractical for flock screening
purposes.
VI. CONTROL IN INFECTED FLOCKS is difficult in the
absence of an ideal test for identifying infected animals. Some basic
steps include:
A. Maintain a sanitary environment at
lambing/kidding time. Clean the teats of ewes before the lamb nurses
if feasible. Move young lambs to "clean" pasture as soon as
is feasible.
B. Identify weight loss ewes or does and isolate
them from the flock and young lambs until a diagnosis is made or until
culled. Do not place these ewes in contact with young animals.
C. Because AGID testing seems to correlate well
with bacterial load and shedding, test the infected flock with AGID
tests prior to lambing to remove the heaviest shedders.
D. Consider depopulation, however, it may be
difficult to repopulate with stock that can be verified free of
infection.
E. Some flocks may be able to raise valuable lambs or
kids as orphans in a separate, clean area in order to establish a new
flock; in other words, establish two flocks much as is done for control of
ovine progressive pneumonia. Lambs should not be allowed to nurse the ewe
and should be raised on milk replacer. The possibility of in utero
infection exists and can cause this technique to fail. As a precaution,
progeny from infected ewes should be culled.
F. Be cautious when using cow colostrum for newborn
lambs or kids. Infected cows may shed Mycobacterium paratuberculosis
in their colostrum and milk, and many dairy herds in some areas of the
US are infected. Pasteurization of colostrum may render it physically
unsuitable but can be used. Some recent reports question the efficacy
of pasteurization in destroying M. paratuberculosis. Be
aware also that acute, fatal anemia has been occasionally reported in
lambs following the use of cow colostrum.
G.Vaccination has been shown in cows, goats, and
sheep to lower the number of clinical cases in the herd or flock but
will not prevent all animals from becoming infected. Some vaccinates
shed bacteria and a proportion will develop clinical signs. Much work
needs to be done with vaccines to evaluate their usefulness as reports
from around the world are somewhat contradictory. Currently available
vaccines may interfere with ELISA and other serology and frequently
cause reactivity in tuberculin testing. There is no licensed vaccine
available for sheep in the US, and in most states the cattle vaccine
is used at the discretion of the state veterinarian’s office.
H. Maintain a closed flock if possible.
I. When purchasing animals, ask questions of the
seller concerning the paratuberculosis status of his flock and
consider serology using ELISA or AGID prior to purchase or addition of
animals to the flock. Alternatively, DNA probe testing may be feasible
and offers the advantage of detecting animals shedding the bacteria.
Ovine Progressive Pneumonia
Synonyms: OPP, maedi, maedi-visna, la bouita,
zwoegerzietke
Ovine progressive pneumonia is a true "slow
virus" infection in sheep related antigenically to the viruses of
caprine/arthritis/encephalitis and a newly isolated retrovirus of sheep.
I. EPIDEMIOLOGY
A. Occurrence is worldwide and relatively recently described with
signs appearing in not only the respiratory system, but also the
joints, mammary gland, and CNS. Recent reports from the United States
and Canada (not statistically based surveys) suggest that about 60
percent of flocks surveyed had at least one infected animal.
B. Signs are related to the presence of a non-oncogenic retrovirus
whose target cell is the macrophage, predominantly those of the above
systems. Cellular response to the viral-infected cell creates the
pathology in the animal.
C. Viral strains of at least two immunogroups are described, and
published literature supports the hypothesis that the infecting strain
may influence disease progression rate and severity. Exposure dose,
and management variables such as ventilation, population density, and
breed may influence the extent of disease seen. Some flocks with
relatively high infection rates have a low incidence of clinical
signs. Others seem to have extensive signs related to the virus.
D. Recent evidence from tissue culture work and extrapolation from
AIDS patients (the virus may mimic pediatric and CNS AIDS) suggests
that presence of intracellular (macrophage) Pasteurella hemolytica
and Corynebacterium pseudotuberculosis may enhance
production of tumor necrosis factor and alpha interferon which could
serve to accelerate viral replication and expression. Since viral
expression enhances the cellular response, this phenomenon may explain
differences in flock presentation with the disease.
E. The virus is spread by colostrum, direct contact with nasal
secretions, and aerosols but is dependent on cellular transmission.
Since the presence of cells in circulating macrophage populations (as
in the blood) is very low, iatrogenic transmission is unlikely in
contrast to bovine leukosis, a retrovirus located in "C"
type lymphocytes.
F. Incubation period from exposure to seroconversion is from one to
six months based on current serological methods. Newer methods (ELISA
and Western Blot) suggest that essentially all infections result in
seropositivity with adequate test methods. New ELISA technology may
offer greater sensitivity than current agar gel immunodiffusion
testing (AGID).
G. Goats can be infected with OPP virus and sheep with CAE virus.
Serology by AGID detects either virus with the same test.
Experimentally, it does not appear that these viruses cause disease in
the alternate specie even though very closely related.
II. SIGNS
A. Usually no clinical signs are seen before two
years-of-age although pathology can be observed in lambs
histologically. Clinical signs can be observed experimentally as early
as two months-of-age with specific strains and infecting doses. (a
model for pediatric AIDS)
B. Signs in the respiratory system are produced by the body’s
cellular response to virus-infected macrophages. Cellular
proliferation, predominantly lymphocytes, cause septa to thicken,
alveolar cells to transform to cuboidal, and peribronchiolar and
perivascular tissues to undergo thickening and hyperplasia. Germinal
centers may form. Eventually, functional tissue is crowded out and the
animal is hypoxic. Bacterial complications of the tissues are common
and superimposed on the progressive change.
C. Signs are those of hypoxia and are gradual and progressive.
Weight loss is usual and may be related to cytokine production as well
as tissue change. Tumor necrosis factor (formerly known as "cachexin")
has been implicated as a possible cause of the weight loss. Bacterial
complications may produce signs of bacterial pneumonia. The "thin
ewe syndrome" includes OPP.
D. Signs related to arthritis, non-indurative mastitis ("hard
bag syndrome"), and CNS lesions may accompany the respiratory
signs and are similarly related to the body’s response to the
infected macrophage.
III. DIAGNOSIS
A. Signs and post mortem lesions are characteristic. Post mortem
reveals heavy non-collapsing lungs with red to reddish-brown
coloration. Lungs may weigh more than 2X normal (normal = 300-500
grams, diseased = 1200 grams), and the pulmonary lymph nodes may be
enlarged to cigar size. Cut sections of the lungs resemble liver.
B. Serum testing by agar gel immunodiffusion is available and has
high specificity. However, sensitivity may be lower than desired for
flock testing. A positive serum test does not indicate a
symptomatic animal has advanced lesions of OPP. As with other
retroviral infections, the infection is permanent, the animal is
usually seropositive within 6 months of infection, and remains so for
life. Like bovine leukemia virus, many animals in a flock may be
infected and only some of them will show clinical disease. A positive
serum test (AGID) for OPP, therefore, only indicates the animal has
the virus.
C. Histopathology is usually diagnostic but early lesions can
resemble those of Mycoplasma infections.
D. AGID testing is currently available but may only detect 65-75
percent of the animals with the virus. ELISA testing, using
recombinant DNA antigen production, has been developed and looks
promising. This test has not yet had extensive field testing but
should be an improvement over AGID.
IV. PREVENTION
A. There is no treatment.
B. Prevention can only be accomplished by establishing an
uninfected flock by serosurvey and culling. Pre-purchase testing,
quarantine, and retesting after six months are necessary to prevent
introduction to the flock. Alternatives to eradication can be
developed for specific flock needs and center around testing and
culling selectively with the ultimate goal of reducing the number of
infected animals to a low level. Removing lambs at birth, before they
can ingest the dam’s colostrum, and rearing them using milk replacer
and heat treated colostrum, or bovine colostrum, will result in
significant reduction in the prevalence of infected animals and
possible eradication. It is labor intensive and potentially costly but
may be preferable to testing and culling in heavily infected flocks.
C. Controversy currently exists as to the economic importance of this
disease. Some studies have failed to show significant economic loss in
terms of lamb growth and conception rate. Others have suggested that
conception rates in seropositive ewes may only be 66 percent of those of
seronegative ewes - a significant loss. Decisions about eradication and
prevention must be made at the flock level with producer goals and disease
history of the flock in mind.
|